An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure

References

• Braunwald E. ACE inhibitors - a cornerstone of the treatment of heart failure. New Engl. J. Med. 1991; 325: 351, 3531. Braunwald E. ACE inhibitors - a cornerstone of the treatment of heart failure. New Engl. J. Med. 1991; 325: 351, 353
   PubMed Web of Science ®Google Scholar
• Bonarjee V., Dickstein K. Novel drugs and current therapeutic approaches in the treatment of heart failure. Drugs 1996; 51(3)347–3582. Bonarjee V., Dickstein K. Novel drugs and current therapeutic approaches in the treatment of heart failure. Drugs 1996; 51(3)347–358
   PubMed Web of Science ®Google Scholar
• Captopril Multi-centre Research Group. A placebo controlled trial of captopril in refractory chronic heart failure. J. Am. CON. Cardiol. 1983; 2: 755, 7633. Captopril Multi-centre Research Group. A placebo controlled trial of captopril in refractory chronic heart failure. J. Am. CON. Cardiol. 1983; 2: 755, 763
   PubMed Web of Science ®Google Scholar
• Captopril Multi-centre Research Group. A co-operative multi-centre study of captopril in congestive heart failure: haemodynamic effects and long term response. Am. Heart J. 1985; 110: 439, 4494. Captopril Multi-centre Research Group. A co-operative multi-centre study of captopril in congestive heart failure: haemodynamic effects and long term response. Am. Heart J. 1985; 110: 439, 449
   PubMedGoogle Scholar
• Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the North Scandinavian enalapril survival study. New Engl. J. Med. 1987; 316: 1429, 14345. Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the North Scandinavian enalapril survival study. New Engl. J. Med. 1987; 316: 1429, 1434
   PubMed Web of Science ®Google Scholar
• The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. New Engl. J. Med. 1991; 325: 293, 3026. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. New Engl. J. Med. 1991; 325: 293, 302
   PubMed Web of Science ®Google Scholar
• Croog S. H., Levine S., Testa M. A. The effects of anti-hypertensive drugs on the quality of life. New Engl. J. Med. 1986; 314: 1657, 16647. Croog S. H., Levine S., Testa M. A. The effects of anti-hypertensive drugs on the quality of life. New Engl. J. Med. 1986; 314: 1657, 1664
   PubMed Web of Science ®Google Scholar
• Magnani B., Magelli C. Captopril in mild heart failure: preliminary observations of a long term, double-blind, placebo-controlled multicentre trial. Postgrad. Med. J. 1986; 62: 153–158, Suppl 18. Magnani B., Magelli C. Captopril in mild heart failure: preliminary observations of a long term, double-blind, placebo-controlled multicentre trial. Postgrad. Med. J. 1986; 62: 153–158, Suppl 1
   PubMed Web of Science ®Google Scholar
• Banas J. S. Preliminary haemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure. Angiology 1989; 40: 396, 4049. Banas J. S. Preliminary haemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure. Angiology 1989; 40: 396, 404
   PubMed Web of Science ®Google Scholar
• Riegger G. A. J. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure. J. Cardiovasc. Pharmacol. 1990; 15: 541–546, (Suppl. 2)10. Riegger G. A. J. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure. J. Cardiovasc. Pharmacol. 1990; 15: 541–546, (Suppl. 2)
   Web of Science ®Google Scholar
• Northbridge D. B., Rose E., Raftery E. D., Lahiri A., Elder A. T., Shaw T. R. D., Henderson E., Dargie H. J. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure. Etrr. Heart J. 1993; 14: 403, 40911. Northbridge D. B., Rose E., Raftery E. D., Lahiri A., Elder A. T., Shaw T. R. D., Henderson E., Dargie H. J. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure. Etrr. Heart J. 1993; 14: 403, 409
   PubMed Web of Science ®Google Scholar
• Gavazzi A., Marioni R. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. J. Hypertension 1994; 12: 589–593, (Suppl. 4)12. Gavazzi A., Marioni R. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. J. Hypertension 1994; 12: 589–593, (Suppl. 4)
   Google Scholar
• Parker M. How should we judge the efficacy of drug therapy in patients with chronic heart failure? The insights of six blind men. J. Am. Coll. Cardiol. 1987; 9: 433, 43813. Parker M. How should we judge the efficacy of drug therapy in patients with chronic heart failure? The insights of six blind men. J. Am. Coll. Cardiol. 1987; 9: 433, 438
   PubMed Web of Science ®Google Scholar
• Butland R. J. A., Pang J., Gross E. R., Woodcock A. A., Geddes D. M. Two six and 12 minute walking tests in respiratory disease. BMJ 1982; 284: 1607, 160814. Butland R. J. A., Pang J., Gross E. R., Woodcock A. A., Geddes D. M. Two six and 12 minute walking tests in respiratory disease. BMJ 1982; 284: 1607, 1608
   PubMed Web of Science ®Google Scholar
• Lipkin D. P., Scriven A. J., Crake T., Poole-Wilson P. A. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1986; 292: 653, 65515. Lipkin D. P., Scriven A. J., Crake T., Poole-Wilson P. A. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1986; 292: 653, 655
   PubMed Web of Science ®Google Scholar
• Sarno J. E., Sarno M. T., Levita M. The functional life scale. Arch. Phys. Med. Rehab. 1973; 54: 214, 22016. Sarno J. E., Sarno M. T., Levita M. The functional life scale. Arch. Phys. Med. Rehab. 1973; 54: 214, 220
   PubMed Web of Science ®Google Scholar
• Cleland J. G. F., Hubbard W. N., Pittard J., Poole-Wilson P. A., Sutton G. C. ACE inhibitors in heart failure. What dose?. Postgrad. Med. J. 1995; 71: 65, 6617. Cleland J. G. F., Hubbard W. N., Pittard J., Poole-Wilson P. A., Sutton G. C. ACE inhibitors in heart failure. What dose?. Postgrad. Med. J. 1995; 71: 65, 66
   PubMed Web of Science ®Google Scholar
• Rudra T., Bayer A. J., Bayley N., Farag R., Pathy M. S. J. Captopril in elderly patients with mild to moderate heart failure. J. Clin. Expl Gerontol. 1989; 11: 29, 4018. Rudra T., Bayer A. J., Bayley N., Farag R., Pathy M. S. J. Captopril in elderly patients with mild to moderate heart failure. J. Clin. Expl Gerontol. 1989; 11: 29, 40
   Web of Science ®Google Scholar
• The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis 9th edn. Little Brown, Boston 199419. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis 9th edn. Little Brown, Boston 1994
   Google Scholar